Income Statement
DARE BIOSCIENCE, INC.
DARE
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
20.00 | 20.00 | 20.00 | 20.00 | - | - | - | - | - | 0.77 | 0.00 | 0.08 |
|
Cost of Revenue
|
0.30 | - | - | - | - | - | - | - | - | - | - | - |
|
Gross Profit
|
19.70 | 20.00 | 20.00 | 20.00 | - | - | - | - | - | 0.77 | - | 0.08 |
|
Operating Expenses
|
14.29 | 23.46 | 33.75 | 41.39 | 39.07 | 27.40 | 14.34 | 16.88 | 11.18 | 37.92 | 37.17 | 20.36 |
|
Research & Development
|
8.20 | 14.21 | 21.54 | 30.04 | 30.62 | 20.77 | 8.55 | 6.41 | 0.98 | 27.57 | 25.95 | 11.77 |
|
Selling, General & Administrative
|
8.76 | 9.16 | 12.11 | 11.24 | 8.35 | 6.55 | 5.27 | 4.66 | 2.70 | 10.36 | 11.22 | 8.59 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
5.42 | -3.46 | -13.75 | -21.39 | -39.07 | -27.40 | -14.34 | -16.88 | -11.18 | -37.15 | -37.17 | -20.28 |
|
Non-Operating Income
|
- | - | - | - | - | - | - | - | - | -2.15 | -2.42 | - |
|
Interest Income
|
0.68 | 0.54 | - | - | - | - | - | - | - | 0.09 | 0.01 | 0.01 |
|
Interest Expense
|
- | - | - | - | - | - | - | - | 0.32 | 2.24 | 2.43 | 1.08 |
|
Other Non-Op Income / Expense
|
0.30 | 0.66 | 0.78 | 0.44 | 0.00 | 0.00 | 0.08 | 0.14 | - | - | - | -3.06 |
|
Income Before Tax
|
-13.54 | -4.05 | -30.16 | -30.95 | -38.70 | -27.40 | -14.26 | -16.81 | -11.52 | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
Net Income
|
-13.40 | -4.05 | -30.16 | -30.95 | -38.70 | -27.40 | -14.26 | -16.74 | -11.50 | -39.31 | -39.59 | -23.34 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
7.05 | -3.46 | -13.75 | -21.39 | -39.07 | -27.40 | -14.34 | -16.88 | -11.18 | -36.89 | -36.98 | -20.15 |
|
Earnings Per Share (Basic)
|
-1.20 | -0.48 | -0.35 | -0.37 | -0.63 | - | - | - | - | - | - | - |
|
Diluted EPS
|
-1.20 | -0.48 | -0.35 | -0.37 | -0.63 | - | - | - | - | - | - | - |
|
Weighted Average Shares
|
11.18 | 8.50 | 87.30 | 84.57 | 61.15 | - | - | - | 3.23 | - | - | - |
|
Diluted Weighted Avg Shares
|
11.18 | 8.50 | 87.30 | 84.57 | 61.15 | - | - | - | 3.23 | - | - | - |
|
Comprehensive Income
|
-13.39 | -4.12 | -30.17 | -31.14 | -38.76 | -27.40 | -15.06 | -16.82 | -11.52 | - | - | - |